Atropos Health
Founded Year
2019Stage
Series B | AliveTotal Raised
$50.33MValuation
$0000Last Raised
$33M | 10 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+150 points in the past 30 days
About Atropos Health
Atropos Health specializes in transforming healthcare data into actionable evidence for the healthcare and life sciences sectors. The company offers solutions that support clinical decisions, optimize health systems, and accelerate clinical research by leveraging a vast network of patient records and analytics tools. Atropos Health primarily serves the healthcare industry, including health systems and life science companies, by providing insights for formulary design, quality improvement programs, and clinical trial emulations. It was founded in 2019 and is based in New York, New York.
Loading...
Atropos Health's Product Videos
_thumbnaila297.png?w=3840)
_thumbnaila297.png?w=3840)
ESPs containing Atropos Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
Atropos Health named as Challenger among 15 other companies, including IQVIA, Tempus, and Datavant.
Atropos Health's Products & Differentiators
ChatRWD™ (Chat Real World Data)
ChatRWD is a generative AI tool that delivers clinical answers more accurately than LLMs such as ChatGPT and Google Gemini. It leverages real-world data from the Atropos Evidence™ Network, which contains over 300 million anonymized patient records. The impact of ChatRWD extends beyond its technical capabilities; it represents a shift in how healthcare data is accessed and utilized. Built on Atropos Health technology, GENEVA OS™, ChatRWD is the first application to incorporate chat-to-database functionality, allowing users to generate high-quality evidence rapidly without compromising data security. GENEVA OS operates locally at the customer’s site, ensuring no patient-level clinical or claims data is exposed to LLMs.
Loading...
Research containing Atropos Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Atropos Health in 5 CB Insights research briefs, most recently on Aug 21, 2024.
Aug 21, 2024
The clinical trials tech market map
Jan 11, 2024
The generative AI in healthcare market map
Expert Collections containing Atropos Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Atropos Health is included in 4 Expert Collections, including Digital Health.
Digital Health
11,305 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
AI 100
100 items
Digital Health 50
50 items
Artificial Intelligence
7,221 items
Atropos Health Patents
Atropos Health has filed 62 patents.
The 3 most popular patent topics include:
- medical equipment
- surgical procedures and techniques
- surgical removal procedures
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/27/2021 | 3/25/2025 | Abdomen, Medical equipment, Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery | Grant |
Application Date | 7/27/2021 |
|---|---|
Grant Date | 3/25/2025 |
Title | |
Related Topics | Abdomen, Medical equipment, Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery |
Status | Grant |
Latest Atropos Health News
Mar 19, 2025
What You Should Know: – Atropos Health , a leader in automating high-quality real-world evidence (RWE), has launched Nodal Patient Deidentification and Query Time Interval Encoding (Nodal Deid) within the GENEVA OS platform for Atropos Evidence Network members. – This advancement allows members to securely enhance patient longitudinal records with deidentified data mapped to the HIPAA safe harbor standard while retaining full control over their data. Linkage occurs only at query time, eliminating the need for data transfers and ensuring source data remains protected. Atropos Health Enhances Real-World Data Utilization with Nodal Deid and GENEVA OS™ Atropos Health, developer of GENEVA OS™, is advancing real-world data (RWD) analysis to close evidence gaps in healthcare. By eliminating traditional data duplication and transfer, Nodal Deid enables secure, real-time queries across the Atropos Evidence Network via ChatRWD®, delivering publication-grade insights in minutes. Mortality data from Veritas Data Research is automatically integrated, with quality assessed through Real World Fitness Score® (RWFS). Health systems can bridge data gaps while maintaining full control and generating passive revenue. Data platforms enhance usability, reduce costs, and increase demand without transactional complexities. Life sciences companies gain transparent access to high-quality, de-identified data, replacing siloed datasets with targeted, multi-source queries. Trusted by industry leaders like Merck and Johnson & Johnson, Atropos Health is redefining real-world evidence, accelerating research, and improving patient care through seamless, high-quality data integration.
Atropos Health Frequently Asked Questions (FAQ)
When was Atropos Health founded?
Atropos Health was founded in 2019.
Where is Atropos Health's headquarters?
Atropos Health's headquarters is located at 169 Madison Avenue, New York.
What is Atropos Health's latest funding round?
Atropos Health's latest funding round is Series B.
How much did Atropos Health raise?
Atropos Health raised a total of $50.33M.
Who are the investors of Atropos Health?
Investors of Atropos Health include Breyer Capital, Presidio Ventures, Emerson Collective, Merck Global Health Innovation Fund, McKesson Ventures and 10 more.
Who are Atropos Health's competitors?
Competitors of Atropos Health include Aetion and 8 more.
What products does Atropos Health offer?
Atropos Health's products include ChatRWD™ (Chat Real World Data).
Who are Atropos Health's customers?
Customers of Atropos Health include Stanford Medical Center, https://www.mayoclinic.org/ , Everycure and TD2.
Loading...
Compare Atropos Health to Competitors
Holmusk is a data analytics and health technology company that focuses on behavioral health within the healthcare sector. The company offers a real-world evidence platform that combines a behavioral health database with analytics and digital solutions to support research and care. Holmusk's services include HolCare EHR+, an electronic health records platform with measurement-based care, and NeuroBlu Research, a data analytics solution for building patient cohorts and exploring datasets. It was founded in 2015 and is based in New York, New York.
Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.
Datavant specializes in data connectivity and logistics for the healthcare sector. The company offers services including real-world data connectivity and data transformation to facilitate the secure and compliant movement of health information. It serves health plans, healthcare providers, life sciences, and government entities by providing solutions for improved healthcare data management. The company was founded in 2017 and is based in Phoenix, Arizona.
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
MediMergent focuses on the collection and analysis of Real-World Evidence (RWE) in the healthcare field. The company provides solutions for patient engagement, clinical trial support, and population health analytics, aimed at integrating patient feedback into healthcare decision-making. MediMergent serves pharmaceutical and life science companies, health insurers, payers, and data analytics aggregators. It was founded in 2014 and is based in Rockville, Maryland.
Decode Health specializes in providing an AI platform as a service (PaaS) that focuses on precision medicine within the healthcare sector. The company offers solutions for pharmaceutical, diagnostic, and technology companies by leveraging multiomics, clinical data, social determinants of health, and other healthcare data sources to deliver actionable insights and accelerate research and development. Decode Health primarily serves the pharmaceutical industry, diagnostic research, and technology platforms seeking to enhance disease management and outcomes. It was founded in 2019 and is based in Nashville, Tennessee.
Loading...